ArticleJournal of immunotherapy and precision oncology2023

Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer.

Ji Son et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.